Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Brucks

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 19, 2014
Svelte integrated delivery system performance examined through diagnostic catheter delivery: the SPEED registryAhmed A Khattab, Freek Nijhoff, Joachim Schofer, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 18, 2009
[Takotsubo syndrome from original description up to now]Samir M Said, Khaled Albouaini, Joerg Herold, et al.
Journal of the American College of Cardiology|February 16, 2019
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial DiseaseYvonne Bausback, Tim Wittig, Andrej Schmidt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 6, 2019
Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trialUlf Teichgräber, Thomas Lehmann, René Aschenbach, et al.
European Heart Journal|January 29, 2020
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventionsSabine Steiner, Andrej Schmidt, Thomas Zeller, et al.
JACC. Cardiovascular Interventions|October 20, 2022
Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE TrialSabine Steiner, Andrej Schmidt, Thomas Zeller, et al.
Cardiovascular and Interventional Radiology|September 11, 2022
Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac TrialUlf Teichgräber, Thomas Lehmann, Maja Ingwersen, et al.
Radiology|March 4, 2020
Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac TrialUlf Teichgräber, Thomas Lehmann, René Aschenbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 2, 2026
Low-dose versus high-dose drug-coated balloons for femoropopliteal lesions: 5-year results from the prospective, randomised COMPARE trialTim Wittig, Andrej Schmidt, Thomas Zeller, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 19, 2014
Svelte integrated delivery system performance examined through diagnostic catheter delivery: the SPEED registryAhmed A Khattab, Freek Nijhoff, Joachim Schofer, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 18, 2009
[Takotsubo syndrome from original description up to now]Samir M Said, Khaled Albouaini, Joerg Herold, et al.
Journal of the American College of Cardiology|February 16, 2019
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial DiseaseYvonne Bausback, Tim Wittig, Andrej Schmidt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 6, 2019
Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trialUlf Teichgräber, Thomas Lehmann, René Aschenbach, et al.
European Heart Journal|January 29, 2020
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventionsSabine Steiner, Andrej Schmidt, Thomas Zeller, et al.
JACC. Cardiovascular Interventions|October 20, 2022
Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE TrialSabine Steiner, Andrej Schmidt, Thomas Zeller, et al.
Cardiovascular and Interventional Radiology|September 11, 2022
Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac TrialUlf Teichgräber, Thomas Lehmann, Maja Ingwersen, et al.
Radiology|March 4, 2020
Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac TrialUlf Teichgräber, Thomas Lehmann, René Aschenbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 2, 2026
Low-dose versus high-dose drug-coated balloons for femoropopliteal lesions: 5-year results from the prospective, randomised COMPARE trialTim Wittig, Andrej Schmidt, Thomas Zeller, et al.
Pageof 2